Call for an instant quote
0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
10 January 2014 09:27
The first once-daily asthma inhaler has been granted approval for use in Britain
The first ever once-a-day asthma inhaler has been approved for use in Britain.
Relvar Ellipta is the name of the new drug, which uniquely combines a steroid dose to reduce inflammation with a new type of long-acting beta2 agonist to open the airways.
asthma travel insurance who is planning to book a dream holiday in 2014 may be hopeful that the new medicine could represent a more convenient and effective way to keep their condition under control.
Some people with asthma will even be able to dispense with their blue inhaler, although others will need to continue to also carry one for when they require immediate relief.
Relvar Ellipta has been approved by the European Commission for prescribing by GPs and asthma specialists to adults and adolescents aged 12 and over, though the NHS drug watchdog NICE is yet to evaluate its cost effectiveness.
The new inhaler can also be used by thousands of people living with the lung disease COPD.
Before granting approval, the European Medicines Agency reviewed results from 10 clinical studies involving 7,783 patients with COPD and 16 trials in 9,326 patients with asthma.
Research has revealed that patients use the grey palm-sized device correctly from the outset and up to six weeks later.
The new treatment offers 24-hour help to asthmatics, many of whom are currently failing to keep the condition under control.
Asthma is an inflammatory disease that constricts the airways and the resulting attacks of breathlessness can be fatal.
More than five million Britons are affected by the condition and many of them experience moderate to severe problems.
Up to three out of four of these patients with moderate to severe problems have "uncontrolled" symptoms despite using one inhaler designed to combat an attack and a second inhaler to keep the airways open.
23 March 2017
Passengers on certain flights into the UK will no longer be able to carry laptops and tablets like iPads in their hand luggage.
22 March 2017
Mountaineers looking to scale the world's highest peak may need to shell out for a GPS device, according to Nepal's tourism chief.
21 March 2017
The effects of being in skyscrapers, at concerts or even walking on wobbly bridges could help scientists understand the experiences of dementia sufferers, researchers are claiming.
18 March 2017
A young actor has released pictures of a lump on her throat that turned out to be thyroid cancer, with hopes the image will raise awareness and alert others who may be suffering from the disease.
17 March 2017
A "promising treatment" for aggressive blood cancer needs more evidence of its effectiveness before NHS doctors will be able to prescribe, a watchdog is warning.
16 March 2017
Millions of Brits are opting for coach holidays over jet-setting and cruises, new research indicates.
15 March 2017
Thousands of flights to and from America's north east have been cancelled in preparation for a "life-threatening" storm poised to hit the country.
14 March 2017
Seniors who experience weight loss should not put it down to the normal ageing process, experts are warning.
11 March 2017
Gatwick Airport is insisting it is still a "credible and deliverable" expansion option, as the airport experienced its busiest ever February.
08 March 2017
Strikes by French air traffic controllers (ATCs) are leading to delays and cancellations across the UK.
10 March 2017
Waiting times for kidney transplant patients have fallen significantly, health officials have said.
09 March 2017
A Dutch snowboarder has been fatally injured in the second avalanche to hit the French Alps in 24 hours.